clinical trial · NCT03094403
To Evaluate the Therapeutic Equivalence and Safety of Azelaic Acid 15% Topical Gel
Sun Pharmaceutical Industries, Inc.·phase1·completed·n = 1,000
RosaceaAzelaic Acid 15% topical gelFinacea® (azelaic acid) Gel, 15%Placebo
brief summary
A Multi-Center, Double-Blind, Randomized, Placebo Controlled, Parallel-Group Study
started
Jul 1, 2016
primary completion
Mar 31, 2017
completion
Apr 1, 2017
last updated
Apr 10, 2024
detailed description
A Multi-Center, Double-Blind, Randomized, Placebo Controlled, Parallel-Group Study, comparing AZELAIC ACID TOPICAL GEL 15% TO FINACEA® and both active treatments to a Placebo Control in the treatment of Moderate of Facial Rosacea.
official title
A Multi-Center, Double-Blind, Randomized, Placebo Controlled, Parallel-Group Study, Comparing Azeliac Acid Gel and Active Treatments to a Placebo Control in the Treatment of Moderate Facial Rosacea.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol